Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Semin Immunopathol. 2019 Sep;41(5):551-563. doi: 10.1007/s00281-019-00754-3. Epub 2019 Sep 10.
Emerging evidence suggest that macrophage and osteoclast are two competing differentiation outcomes from myeloid progenitors. In this review, we summarize recent advances in the understanding of the molecular mechanisms controlling the polarization of macrophage and osteoclast. These include nuclear receptors/transcription factors such as peroxisome proliferator-activated receptor γ (PPARγ) and estrogen-related receptor α (ERRα), their transcription cofactor PPARγ coactivator 1-β (PGC-1β), metabolic factors such as mitochondrial complex I (CI) component NADH:ubiquinone oxidoreductase iron-sulfur protein 4 (Ndufs4), as well as transmembrane receptors such as very-low-density-lipoprotein receptor (VLDLR). These molecular rheostats promote osteoclast differentiation but suppress proinflammatory macrophage activation and inflammation, by acting lineage-intrinsically, systemically or cross generation. These findings provide new insights to the understanding of the interactions between innate immunity and bone remodeling, advancing the field of osteoimmunology.
新出现的证据表明,巨噬细胞和成骨细胞是骨髓祖细胞分化的两个相互竞争的结果。在这篇综述中,我们总结了近年来对控制巨噬细胞和破骨细胞极化的分子机制的理解的最新进展。这些包括核受体/转录因子,如过氧化物酶体增殖物激活受体γ (PPARγ) 和雌激素相关受体α (ERRα),它们的转录共因子过氧化物酶体增殖物激活受体γ共激活因子 1-β (PGC-1β),代谢因子,如线粒体复合物 I (CI) 成分烟酰胺腺嘌呤二核苷酸脱氢酶:泛醌氧化还原酶铁硫蛋白 4 (Ndufs4),以及跨膜受体,如极低密度脂蛋白受体 (VLDLR)。这些分子变阻器通过内在作用、系统性作用或跨代作用促进破骨细胞分化,但抑制促炎巨噬细胞的激活和炎症。这些发现为理解先天免疫和骨重塑之间的相互作用提供了新的见解,推进了骨免疫学领域的发展。